Corcept Therapeutics (CORT) Tops Q4 EPS by 1c
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 11/4/2026
- Wall Street rallies after Democrats win Congress; data center stocks slide
- What the Democratic sweep in the midterms means for markets
- SpaceX, Tesla slide as election risks mount, Morgan Stanley turns bullish
- CVS Health plans to split into two public companies by 2028
- AI sector outlook darkens as Democrat wins threaten $900B capex cycle
Tweet
Share
E-mailGet Alerts CORT Hot Sheet
Price: $75.50 -7.85%
Financial Fact:
Net loss and comprehensive loss: 2.59M
Today's EPS Names:
ATS, SICP, FTCO, More
Financial Fact:
Net loss and comprehensive loss: 2.59M
Today's EPS Names:
ATS, SICP, FTCO, More
Join SI Premium – FREE
Corcept Therapeutics (NASDAQ: CORT) reported Q4 EPS of $0.28, $0.01 better than the analyst estimate of $0.27. Revenue for the quarter came in at $135.4 million versus the consensus estimate of $130.31 million.
For earnings history and earnings-related data on Corcept Therapeutics (CORT) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Corcept Therapeutics (CORT) PT Raised to $173 at Piper Sandler
- Netflix gains after Ackman endorsement and AI feature launch
- Berkshire Hathaway hits 52-week high on election rally
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
